Physician profile
Eric J Strauss
NPI 1508061748
$240,772.48
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $17K · 2021: $8,385 · 2022: $47K · 2023: $31K · 2024: $49K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Honoraria: $21K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $21K · Travel and Lodging: $9,584 · Food and Beverage: $3,011 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,968.75 |
| Honoraria | $21,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,900.00 |
| Travel and Lodging | $9,584.38 |
| Food and Beverage | $3,011.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $699.95 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $102,820.41 | 2019-2025 | Maci |
| Smith+Nephew, INC. | $99,726.29 | 2019-2025 | Q-Fix, Biosure, Spatial Frame |
| Globus Medical, INC. | $9,687.50 | 2024 | |
| Arthrex, INC. | $9,675.39 | 2019-2025 | Knee & Hip Implants Meniscal Repair Fiberstitch |
| Arcuro Medical INC | $7,699.95 | 2022-2023 | Superball |
| Gotham Surgical Solutions & Devices, INC. | $2,955.00 | 2019-2022 | |
| Joint Restoration Foundation, INC. | $2,730.97 | 2019-2022 | |
| Fidia Pharma USA INC. | $2,500.00 | 2019 | |
| Depuy Synthes Products, INC. | $1,170.00 | 2022 | |
| Suvon Surgical LLC | $689.82 | 2023-2025 | |
| Horizon Therapeutics Plc | $316.59 | 2019-2022 | |
| Stryker Corporation | $166.57 | 2021 | |
| Cgg Medical INC | $162.06 | 2025 | |
| Miach Orthopaedics, INC. | $161.34 | 2024 | |
| Lifenet Health | $122.68 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $102.93 | 2025 | |
| Brainlab, INC. | $55.00 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
| Trice Medical, INC. | $11.45 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$27,388.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.